IL-1β is commonly recognized as a major tumor-promoting cytokine and his role is associated with unfavourable prognostic outcomes linked with cancer-related inflammation and compromised immune function (Huang C. F. et al., 2017; Chen L. et al., 2018). This evidence concerns the gene IL1B and cancer.